Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of norepinephrine infusion on hepatic blood flow during goal-directed hemodynamic therapy
2018-004139-66Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of norepinephrine in hepatic blood flow alteration, sponsored by Ghent University Hospital. Primary endpoint: Hepatic blood flow and hepatic vascular pressures. Started Mar 2019; status: completed.
02
Drugs
norepinephrine
03
Conditions
hepatic blood flow alteration
Beyond the preview
Go deeper on 2018-004139-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004139-66.